Dollars at work
Since 2008, The Enbridge® Ride to Conquer Cancer® has raised over $155 million for the Princess Margaret Cancer Centre and is Canada’s largest cycling fundraiser. The Ride to Conquer Cancer series is Canada’s largest peer-to-peer fundraising event.
Princess Margaret Cancer Centre is one of the top 5 cancer research centres in the world and is home to the largest clinical trials program in Canada. It has the largest radiation medicine program under one roof in the world and has the largest surgical oncology program in the country. As global leaders in cancer care, The Princess Margaret has the expertise to treat over 200 types of cancers including the rarest forms of the disease.
Funds raised through the Enbridge Ride to Conquer Cancer support Personalized Cancer Medicine research, treatment advances, education and new standards of care at Princess Margaret, across Ontario, and around the world.
Personalized Cancer Medicine is a multi-faceted, integrated approach to cancer care that focuses on the unique nature of each patient. Because every patient is unique, every patient’s cancer is different. Funds raised through the Ride are enabling the scientists and research clinicians at Princess Margaret Cancer Centre to better understand the unique nature of each cancer and each patient, which are leading to more effective, targeted and less toxic treatments for cancer patients.
Funds raised by Riders are allocated into four main areas of Personalized Cancer Medicine:
We understand how important it is to make smart investments with donor dollars and we strategically invest in projects that have a clear impact on patients. To learn more about how we are investing donor dollars, click here.
Detecting cancers early leads to better outcomes. The Princess Margaret is working to develop new Molecular Imaging Technology that can see tiny cancers. They are also making advances with Biomarkers, indicators of cancer that can be detected through blood and serum tests.
The Princess Margaret is underway testing new equipment and procedures which help determine the specific genetic mutation of a patient. This information enables their doctors and researchers to recommend the optimal combination of drug and other therapies to treat the patient.
Researchers, scientists and doctors at Princess Margaret Cancer Centre are developing ways to make surgery, radiation and drug treatments more targeted to the cells with cancer. This approach will leave healthy tissue intact, minimizing toxic side effects and new treatments such as Immune Therapy will help lead to better survival rates.
Princess Margaret Cancer Centre is working to provide programs and strategies to help patients living with cancer and their families to cope with the emotional and physical effects of cancer treatment. The award-winning survivorship, patient education and psychosocial support programs help reduce stress and improve the overall patient experience.
Since 2008, The Princess Margaret has also used funds raised through the Ride to support other core cancer areas including:
- Programs - Tumor Immunotherapy program led by Dr. Pamela Ohashi, Dr. Tak Mak and Dr. Lillian Sui; Cancer Stem Cell program led by Dr. John Dick; and Tumor Hypoxia program led by Dr. Brad Wouters and Dr. Michael Milosevic.
- Research Platforms - Image-Guided Technology and Robotic Surgery; Clinical Trials that support specific cancer types; BioBank initiative.
- People - Over 1,200 people employed in our research enterprise including 64 scientists, 315 clinical researchers and 450 trainees.